These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 24238148)

  • 1. Time-to-diagnosis and symptoms of myeloma, lymphomas and leukaemias: a report from the Haematological Malignancy Research Network.
    Howell DA; Smith AG; Jack A; Patmore R; Macleod U; Mironska E; Roman E
    BMC Hematol; 2013 Oct; 13(1):9. PubMed ID: 24238148
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 'Unpacking' pathways to lymphoma and myeloma diagnosis: Do experiences align with the Model of Pathways to Treatment? Findings from a UK qualitative study with patients and relatives.
    Howell D; Hart R; Smith A; Macleod U; Patmore R; Roman E
    BMJ Open; 2020 Feb; 10(2):e034244. PubMed ID: 32054627
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk factors and time to symptomatic presentation in leukaemia, lymphoma and myeloma.
    Howell DA; Warburton F; Ramirez AJ; Roman E; Smith AG; Forbes LJ
    Br J Cancer; 2015 Sep; 113(7):1114-20. PubMed ID: 26325101
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnostic timeliness in adolescents and young adults with cancer: a cross-sectional analysis of the BRIGHTLIGHT cohort.
    Herbert A; Lyratzopoulos G; Whelan J; Taylor RM; Barber J; Gibson F; Fern LA
    Lancet Child Adolesc Health; 2018 Mar; 2(3):180-190. PubMed ID: 29503844
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Place of death in haematological malignancy: variations by disease sub-type and time from diagnosis to death.
    Howell DA; Wang HI; Smith AG; Howard MR; Patmore RD; Roman E
    BMC Palliat Care; 2013 Nov; 12(1):42. PubMed ID: 24245578
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment decision making (TDM): a qualitative study exploring the perspectives of patients with chronic haematological cancers.
    McCaughan D; Roman E; Smith A; Patmore R; Howell D
    BMJ Open; 2022 Mar; 12(3):e050816. PubMed ID: 35351694
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Italian cancer figures--Report 2015: The burden of rare cancers in Italy.
    ; Busco S; Buzzoni C; Mallone S; Trama A; Castaing M; Bella F; Amodio R; Bizzoco S; Cassetti T; Cirilli C; Cusimano R; De Angelis R; Fusco M; Gatta G; Gennaro V; Giacomin A; Giorgi Rossi P; Mangone L; Mannino S; Rossi S; Pierannunzio D; Tavilla A; Tognazzo S; Tumino R; Vicentini M; Vitale MF; Crocetti E; Dal Maso L
    Epidemiol Prev; 2016; 40(1 Suppl 2):1-120. PubMed ID: 26951748
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Variations in specialist palliative care referrals: findings from a population-based patient cohort of acute myeloid leukaemia, diffuse large B-cell lymphoma and myeloma.
    Howell DA; Wang HI; Roman E; Smith AG; Patmore R; Johnson MJ; Garry AC; Howard MR
    BMJ Support Palliat Care; 2015 Dec; 5(5):496-502. PubMed ID: 24644210
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incurable but treatable: Understanding, uncertainty and impact in chronic blood cancers-A qualitative study from the UK's Haematological Malignancy Research Network.
    Howell DA; McCaughan D; Smith AG; Patmore R; Roman E
    PLoS One; 2022; 17(2):e0263672. PubMed ID: 35143569
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Symptoms and patient factors associated with diagnostic intervals for pancreatic cancer (SYMPTOM pancreatic study): a prospective cohort study.
    Walter FM; Mills K; Mendonça SC; Abel GA; Basu B; Carroll N; Ballard S; Lancaster J; Hamilton W; Rubin GP; Emery JD
    Lancet Gastroenterol Hepatol; 2016 Dec; 1(4):298-306. PubMed ID: 28404200
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Time from Symptom Onset to Diagnosis and Treatment among Haematological Malignancies: Influencing Factors and Associated Negative Outcomes.
    Dapkevičiūtė A; Šapoka V; Martynova E; Pečeliūnas V
    Medicina (Kaunas); 2019 Jun; 55(6):. PubMed ID: 31163661
    [No Abstract]   [Full Text] [Related]  

  • 12. Myeloma: Patient accounts of their pathways to diagnosis.
    Howell DA; Hart RI; Smith AG; Macleod U; Patmore R; Cook G; Roman E
    PLoS One; 2018; 13(4):e0194788. PubMed ID: 29617390
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Haematological Malignancy Research Network (HMRN): a new information strategy for population based epidemiology and health service research.
    Smith A; Roman E; Howell D; Jones R; Patmore R; Jack A;
    Br J Haematol; 2010 Mar; 148(5):739-53. PubMed ID: 19958356
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bromodomain inhibitor OTX015 in patients with lymphoma or multiple myeloma: a dose-escalation, open-label, pharmacokinetic, phase 1 study.
    Amorim S; Stathis A; Gleeson M; Iyengar S; Magarotto V; Leleu X; Morschhauser F; Karlin L; Broussais F; Rezai K; Herait P; Kahatt C; Lokiec F; Salles G; Facon T; Palumbo A; Cunningham D; Zucca E; Thieblemont C
    Lancet Haematol; 2016 Apr; 3(4):e196-204. PubMed ID: 27063978
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Factors related with symptom duration until diagnosis and treatment of symptomatic colorectal cancer.
    Esteva M; Leiva A; Ramos M; Pita-Fernández S; González-Luján L; Casamitjana M; Sánchez MA; Pértega-Díaz S; Ruiz A; Gonzalez-Santamaría P; Martín-Rabadán M; Costa-Alcaraz AM; Espí A; Macià F; Segura JM; Lafita S; Arnal-Monreal F; Amengual I; Boscá-Watts MM; Hospital A; Manzano H; Magallón R;
    BMC Cancer; 2013 Feb; 13():87. PubMed ID: 23432789
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Health-related quality of life in early breast cancer.
    Groenvold M
    Dan Med Bull; 2010 Sep; 57(9):B4184. PubMed ID: 20816024
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Understanding symptom appraisal and help-seeking in people with symptoms suggestive of pancreatic cancer: a qualitative study.
    Mills K; Birt L; Emery JD; Hall N; Banks J; Johnson M; Lancaster J; Hamilton W; Rubin GP; Walter FM
    BMJ Open; 2017 Sep; 7(9):e015682. PubMed ID: 28871013
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Variation in promptness of presentation among 10,297 patients subsequently diagnosed with one of 18 cancers: evidence from a National Audit of Cancer Diagnosis in Primary Care.
    Keeble S; Abel GA; Saunders CL; McPhail S; Walter FM; Neal RD; Rubin GP; Lyratzopoulos G
    Int J Cancer; 2014 Sep; 135(5):1220-8. PubMed ID: 24515930
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Generic Model for Follicular Lymphoma: Predicting Cost, Life Expectancy, and Quality-Adjusted-Life-Year Using UK Population-Based Observational Data.
    Wang HI; Roman E; Crouch S; Aas E; Burton C; Patmore R; Smith A
    Value Health; 2018 Oct; 21(10):1176-1185. PubMed ID: 30314618
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of cancer diagnostic intervals before and after implementation of NICE guidelines: analysis of data from the UK General Practice Research Database.
    Neal RD; Din NU; Hamilton W; Ukoumunne OC; Carter B; Stapley S; Rubin G
    Br J Cancer; 2014 Feb; 110(3):584-92. PubMed ID: 24366304
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.